FMC Corporation 2004 Annual Report (10-K) Summary
Business Context and Reporting Period
This Form 10-K covers the fiscal year ended December 31, 2004. FMC Corporation is a diversified, global chemical company operating in three segments: Agricultural Products (insecticides and herbicides), Specialty Chemicals (BioPolymer food/pharma ingredients and lithium), and Industrial Chemicals (soda ash, hydrogen peroxide, and phosphorus chemicals). The company spun off its machinery business (FMC Technologies) in 2001. North America remains the largest geographic market, generating 43% of 2004 revenue.
Key Financial Metrics
| Metric (in Millions) | 2004 | 2003 |
|---|---|---|
| Revenue | $2,051.2 | $1,921.4 |
| Net Income | $160.2 | $26.5 |
| Diluted EPS | $4.28 | $0.75 |
| Operating Cash Flow | $238.7 | $220.7 |
| Total Debt | $923.2 | $1,050.2 |
| Long-Term Debt | $822.2 | $1,033.4 |
| Cash and Equivalents | $212.4 | $57.0 |
Segment Performance (2004 Operating Profit):
- Agricultural Products: $118.4 million (Revenue: $703.5 million)
- Specialty Chemicals: $96.1 million (Revenue: $538.0 million)
- Industrial Chemicals: $57.3 million (Revenue: $813.7 million)
Material Changes vs. Prior Period
- Revenue Growth: Consolidated revenue increased 7% to $2.05 billion, driven by higher volumes and favorable foreign currency translation across all segments.
- Profitability Surge: Net income jumped significantly from $26.5 million to $160.2 million. This was primarily due to a 44% increase in Agricultural Products operating profit and a 69% increase in Industrial Chemicals operating profit.
- Debt Reduction: Total debt decreased by approximately $127 million. The company refinanced its credit agreement in October 2004, replacing a $241.8 million term loan with a new $100 million term loan and a $400 million revolving facility. This resulted in a $9.9 million write-off of deferred financing fees.
- Joint Venture Restructuring: The Astaris joint venture (phosphorus chemicals) completed a restructuring in 2004, reducing FMC's share of restructuring charges from $53.3 million in 2003 to $11.5 million in 2004.
- Tax Adjustments: 2004 net income included a significant after-tax tax benefit of approximately $71 million due to IRS pronouncements and valuation allowance adjustments.
Guidance, Outlook, and Risks
2005 Outlook: Management expects continued earnings growth in 2005, driven primarily by a recovery in the Industrial Chemicals segment (specifically higher soda ash prices) and reduced interest expense. Agricultural Products sales are expected to be flat, while Specialty Chemicals are projected to see mid-single-digit revenue growth.
Key Risks and Contingencies:
- Environmental Liabilities: Total environmental reserves were $180.2 million (net of recoveries) at year-end. Management estimates reasonably possible loss contingencies may exceed accrued amounts by up to $75 million. Significant spending is expected at the Pocatello, Idaho site ($62 million projected for 2005).
- Legal Proceedings: FMC faces approximately 38,000 pending asbestos-related claims (though most have been dismissed historically). The company is also subject to antitrust investigations regarding hydrogen peroxide in Europe and the U.S., and microcrystalline cellulose in the U.S.
- Joint Venture Partner: Solutia, FMC's 50% partner in Astaris, filed for Chapter 11 bankruptcy in December 2003. While Astaris refinanced in February 2005, eliminating FMC's "keepwell" payment obligations, the bankruptcy status of Solutia remains a risk factor.
- Market Risks: Exposure to foreign currency fluctuations (Euro, Brazilian Real) and energy cost volatility.
Investor Verification Checklist
- Debt Covenants: Verify compliance with the new 2004 Credit Agreement leverage and interest coverage ratios.
- Environmental Reserves: Monitor the adequacy of the $180.2 million reserve against actual remediation costs, particularly at the Pocatello and New Jersey sites.
- Astaris Performance: Track the profitability of the Astaris joint venture post-restructuring and the impact of Solutia's bankruptcy proceedings on future payments.
- Antitrust Litigation: Assess potential financial impact from pending class-action lawsuits regarding hydrogen peroxide and microcrystalline cellulose.
- Dividend Policy: Note that the company paid no dividends in 2004 and does not expect to pay any in 2005, focusing instead on debt reduction.